Turkish Neonatal Society position paper for stem cell therapy in neonates
Makaleler > Tam Makale · 2024
Yazarlar: Merih Cetinkaya, Esin Koc, Betul Acunas, Mete AKISU, Saadet Arsan, Fuat Emre Canpolat, Dilek Dilli, Zeynep Ince, Nilgun Koksal, Abdullah Kumral, Eren Ozek, Hasan Ozkan, Ayse Korkmaz Toygar, Sule Yigit, Aysegul Zenciroglu, Mehmet Vural
Global Pediatrics, Uluslararası, Scopus, 2024, cilt 11, ss 100239-100239
DOI: 10.1016/j.gpeds.2024.100239
Özet
Stem cell (SC) therapy has been proposed as a promising therapeutic modality in neonatology, especially for prevention and/or treatment of several interactable diseases such as bronchopulmonary dysplasia, intraventricular hemorrhage, hypoxic-ischemic encephalopathy and others. However, there are several uncertainities in terms of indications, timing, dosage, and safety of SC therapy for routine clinical use in neonates. Herein, a group of Turkish Neonatal Society members evaluated the systematic reviews, meta-analyses, clinical and experimental studies and also case-reports in the literature about the usage of SC therapy in neonatal diseases.